Abstract
5-Substituted uracils were reported to be important core structure of diverse therapeutics. Herein, novel mixed ligand transition metal (Mn, Cu, Ni) complexes of 5-iodouracil (5Iu) with 8-hydroxyquinoline or 8HQ (1-3) and 5- nitrouracil (5Nu) with 8HQ (4-6) have been synthesized. The metal complexes 1-6 exert significant cytotoxicity against HepG2, A-549, HuCCA-1 and MOLT-3 cell lines. Particularly, the cytotoxicities of tested complexes against HepG2 cells show their IC50 values lower than the reference drug. Cu complex of 5Nu (5Nu-Cu-8HQ, 5) is the most potent and promising cytotoxic compound. Mn complex of 5Iu (5Iu-Mn-8HQ, 1) is shown to be the most potent antioxidant. This finding reveals the application of using simple and commercially available bioactive ligands like 5Iu, 5Nu and 8HQ for the design and construction of new lead compounds with significant and promising bioactivities.
Keywords: 5-iodouracil, 5-nitrouracil, Metal complex, SOD and cytotoxic activities, Uracil Derivatives, anticancer drug, antioxidant activity, Melting points, Gibco and Hyclone laboratories, 8HQ, olefinic electron donor, Cytotoxic Activity, Superoxide Dismutase, Antioxidative Activity
Letters in Drug Design & Discovery
Title: Metal Complexes of Uracil Derivatives with Cytotoxicity and Superoxide Scavenging Activity
Volume: 9 Issue: 3
Author(s): Supaluk Prachayasittikul, Apilak Worachartcheewan, Ratchanok Pingaew, Thummaruk Suksrichavalit, Chartchalerm Isarankura-Na-Ayudhya, Somsak Ruchirawat and Virapong Prachayasittikul
Affiliation:
Keywords: 5-iodouracil, 5-nitrouracil, Metal complex, SOD and cytotoxic activities, Uracil Derivatives, anticancer drug, antioxidant activity, Melting points, Gibco and Hyclone laboratories, 8HQ, olefinic electron donor, Cytotoxic Activity, Superoxide Dismutase, Antioxidative Activity
Abstract: 5-Substituted uracils were reported to be important core structure of diverse therapeutics. Herein, novel mixed ligand transition metal (Mn, Cu, Ni) complexes of 5-iodouracil (5Iu) with 8-hydroxyquinoline or 8HQ (1-3) and 5- nitrouracil (5Nu) with 8HQ (4-6) have been synthesized. The metal complexes 1-6 exert significant cytotoxicity against HepG2, A-549, HuCCA-1 and MOLT-3 cell lines. Particularly, the cytotoxicities of tested complexes against HepG2 cells show their IC50 values lower than the reference drug. Cu complex of 5Nu (5Nu-Cu-8HQ, 5) is the most potent and promising cytotoxic compound. Mn complex of 5Iu (5Iu-Mn-8HQ, 1) is shown to be the most potent antioxidant. This finding reveals the application of using simple and commercially available bioactive ligands like 5Iu, 5Nu and 8HQ for the design and construction of new lead compounds with significant and promising bioactivities.
Export Options
About this article
Cite this article as:
Prachayasittikul Supaluk, Worachartcheewan Apilak, Pingaew Ratchanok, Suksrichavalit Thummaruk, Isarankura-Na-Ayudhya Chartchalerm, Ruchirawat Somsak and Prachayasittikul Virapong, Metal Complexes of Uracil Derivatives with Cytotoxicity and Superoxide Scavenging Activity, Letters in Drug Design & Discovery 2012; 9 (3) . https://dx.doi.org/10.2174/157018012799129918
DOI https://dx.doi.org/10.2174/157018012799129918 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cratylia mollis Lectin: A Versatile Tool for Biomedical Studies
Current Bioactive Compounds Recent Anticancer Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Baculovirus Gene Delivery: A Flexible Assay Development Tool
Current Gene Therapy Place of Nanofiltration for Assuring Viral Safety of Biologicals
Current Nanoscience Molecular Targeting of Lymphatics for Therapy
Current Pharmaceutical Design Research Progress of Exogenous Plant MiRNAs in Cross-Kingdom Regulation
Current Bioinformatics DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design Important Classes of Bioactive Alkaloids from Marine Ascidians: Structures, Isolation and Bioactivity
Current Topics in Medicinal Chemistry Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Biomarkers in Molecularly Targeted Therapy for Cancer
Recent Patents on Biomarkers Synthetic Peptides Derived from the C-Terminal Region of Lys49 Phospholipase A2 Homologues from Viperidae Snake Venoms: Biomimetic Activities and Potential Applications
Current Pharmaceutical Design Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine Knocking Down Gene Expression with Dendritic Vectors
Mini-Reviews in Medicinal Chemistry Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Perspectives of Fullerenes, Dendrimers, and Heterocyclic Compounds Application in Tumor Treatment
Recent Patents on Nanomedicine Role of Angiopoietin-like 4 (ANGPTL4), a Member of Matricellular Proteins: from Homeostasis to Inflammation and Cancer Metastasis
Current Angiogenesis (Discontinued) Peptides for In Vivo Target-Specific Cancer Imaging
Mini-Reviews in Medicinal Chemistry Disordered Interactome of Human Papillomavirus
Current Pharmaceutical Design RNA Metabolism in Neurodegenerative Disease
Current Chemical Biology VFP: A Visual Algorithm for Predicting Gene Fusion in RNA-Seq Data
Current Bioinformatics